Chapter 54 Chapter 54 HIV and Osteoporosis Copyright © 2013 Elsevier Inc. All rights reserved.

Slides:



Advertisements
Similar presentations
1 Copyright © 2010, Elsevier Inc. All rights Reserved Fig 4.1 Chapter 4.
Advertisements

Chapter 68 Chapter 68 Fracture Risk Assessment: The Development and Application of FRAX ® Copyright © 2013 Elsevier Inc. All rights reserved.
Aging with HIV infection Bill Powderly MD School of Medicine and Medical Sciences University College Dublin Ireland.
Chapter 72 Chapter 72 Calcium in the Treatment of Osteoporosis Copyright © 2013 Elsevier Inc. All rights reserved.
HCV Co-infection is Associated with a High Risk of Osteoporotic Fractures Among HIV Patients Roger Bedimo, MD; Henning Drechsler, MD; Song Zhang, PhD;
1 Chapter 24 - Renal Cortical and Medullary Microcirculations: Structure and Function Copyright © 2013 Elsevier Inc. All rights reserved.
1 Chapter 33 - Sodium and Chloride Transport: Proximal Nephron Copyright © 2013 Elsevier Inc. All rights reserved.
Chapter 62: Osteoporosis in Men
Aromatase inhibitor-associated bone loss in breast cancer patients is distinct from postmenopausal osteoporosis  Peyman Hadji  Critical Reviews in Oncology.
Ronald D. Emkey, MD, Mark Ettinger, MD 
Modeling Constraints with Parametrics
Copyright © 2016 Elsevier Inc. All rights reserved.
Chapter 41 Work-Related Musculo-Skeletal Disorders
Chapter 65 - The Hormonal Regulation of Calcium Metabolism
Copyright © 2012, Elsevier Inc. All rights Reserved.
Chapter 11.
Copyright © 2013 Elsevier Inc. All rights reserved.
Copyright © 2012, Elsevier Inc. All rights Reserved.
Copyright © 2013 Elsevier Inc. All rights reserved.
Copyright © 2012, Elsevier Inc. All rights Reserved.
Copyright © 2013 Elsevier Inc. All rights reserved.
Chapter 10.
Chapter 28 - Renal Hyperplasia and Hypertrophy
Copyright © 2014, 2000, 1992 Elsevier Inc. All rights reserved.
Copyright © 2012, Elsevier Inc. All rights Reserved.
Copyright © 2013 Elsevier Inc. All rights reserved.
Copyright © 2013 Elsevier Inc. All rights reserved.
Copyright © 2013 Elsevier Inc. All rights reserved.
Modeling Cross-Cutting Relationships with Allocations
Portable Biotechnology
© 2012 Elsevier, Inc. All rights reserved.
Copyright © 2013 Elsevier Inc. All rights reserved.
Modeling Text-Based Requirements and their Relationship to Design
Modeling Functionality with Use Cases
Customizing SysML for Specific Domains
Copyright © 2012, Elsevier Inc. All rights Reserved.
Copyright © 2013 Elsevier Inc. All rights reserved.
Copyright © 2016 Elsevier Inc. All rights reserved.
Chapter 91 Epidemiology of Headache in Women:
Copyright © 2013 Elsevier Inc. All rights reserved.
IntroductionMolecular Structure and Reactivity
Copyright © 2013 Elsevier Inc. All rights reserved.
Copyright © 2013 Elsevier Inc. All rights reserved.
Copyright © 2013 Elsevier Inc. All rights reserved.
Chapter 12.
Chapter 6.
Copyright © 2012, Elsevier Inc. All rights Reserved.
© 2012 Elsevier, Inc. All rights reserved.
Chapter 103 Long-Term Care: The Global Impact
Chapter 01.
Copyright © 2013 Elsevier Inc. All rights reserved.
Copyright © 2013 Elsevier Inc. All rights reserved.
Chapter 08.
Copyright © 2013 Elsevier Inc. All rights reserved.
Chapter 64 - Renal Calcium Metabolism
Copyright © 2013 Elsevier Inc. All rights reserved.
Chapter 57 - Renal Ammonium Ion Production and Excretion
© 2015 Elsevier, Inc. All rights reserved.
Copyright © 2013 Elsevier Inc. All rights reserved.
Copyright © 2013 Elsevier Inc. All rights reserved.
Copyright © 2012, Elsevier Inc. All rights Reserved.
Chapter 15 Contraception
Chapter 29 - Stem Cells and Generation of New Cells in the
Chapter 78 Vaccination and Screening in Cervical Cancer
Copyright © 2013 Elsevier Inc. All rights reserved.
Chapter 15.
Chapter 77 Cervical Cancer: Burden of Disease
Chapter 20 Assisted Reproductive Technologies
Chapter 3.
© 2015 Elsevier, Inc. All rights reserved.
Presentation transcript:

Chapter 54 Chapter 54 HIV and Osteoporosis Copyright © 2013 Elsevier Inc. All rights reserved.

FIGURE 54.1 Comparison of fracture prevalence in HIV-infected vs. non-HIV-infected patients according to gender and age group. Source: from Triant V A et al. JCEM 2008;93:3499–3504 (© Endocrine Society 2008) [23]. 2

Copyright © 2013 Elsevier Inc. All rights reserved. FIGURE 54.2 Evolution of bone mineral density (BMD) in men (thin solid line) and women (thick solid line) with superimposed trajectories of BMD in HIV-positive (HIV+) men (thin dashed lines) and HIV-negative women (thick dashed lines). In both HIV-positive men and women, initiation of antiretroviral therapy (ART) is associated with an accelerated rate of bone loss which stabilizes after 1 to 2 years of ART. In younger men and women on established ART regimens, BMD changes at the same rate as in uninfected individuals; however in postmenopausal women and older men, rate of bone loss may be higher in HIV-infected than uninfected individuals. Source: adapted from Orwoll ES et al. Endocr Rev. 1995;16(1):87–116. 3